Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Introduction and Uptake of New Medical Technologies in the Australian Health Care System: A Qualitative Study

    Access Status
    Fulltext not available
    Authors
    Gallego, G.
    Casey, R.
    Norman, Richard
    Goodall, S.
    Date
    2011
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Gallego, G. and Casey, R. and Norman, R. and Goodall, S. 2011. Introduction and Uptake of New Medical Technologies in the Australian Health Care System: A Qualitative Study. Health Policy. 102: pp. 152-158.
    Source Title
    Health Policy
    DOI
    10.1016/j.healthpol.2011.04.003
    ISSN
    0168-8510
    URI
    http://hdl.handle.net/20.500.11937/32395
    Collection
    • Curtin Research Publications
    Abstract

    Objective: The aim of this study was to explore the views and perceptions of stakeholders about the current national health technology assessment process conducted by the Medical Services Advisory Committee (MSAC) and its role in the uptake and diffusion of new medical technologies in Australia.Methods: Data collection occurred over a nine month period (August 2008–April 2009). Twenty in-depth, semi-structured interviews were conducted with individuals from four stakeholders groups: (i) MSAC members and evaluators, (ii) academic and health technology assessment experts, (iii) medical industry representatives and (iv) medical specialists. Interviews were digitally recorded, transcribed verbatim and coded using a constant comparative method.Results: Respondents expressed a consensus opinion that the MSAC process is generally fair and transparent, and has been increasingly so over time. The process was described as “flexible” and “intuitive” yet also “idiosyncratic” due to the nature of the technologies being appraised. Approval by MSAC was generally reported to be increasingly important once a technology becomes more widely used. While successful MSAC approval was felt to be important for widespread distribution of a new technology, it was viewed more as a “facilitator of the uptake of new technologies” as opposed to a primary “driver” of technology uptake. Instead, other factors were identified as providing the actual impetus for the uptake of new technologies, with MSAC approval and reimbursement eventually helpingfacilitate more widespread diffusion.Conclusions: MSAC’s decision making process is perceived as fair but with room for improvement. Its role in the uptake and diffusion of new medical technologies in Australia is limited. MSAC does not act as a barrier to significant market penetration of new procedures and medical technologies. However reimbursement is a trigger for increased use.

    Related items

    Showing items related by title, author, creator and subject.

    • General practitioners' perceptions on home medicines reviews: A qualitative analysis
      Dhillon, A.; Hattingh, H. Laetitia; Stafford, A.; Hoti, Kreshnik (2015)
      Background: Home Medicines Review (HMR) is an Australian initiative introduced in 2001 to improve quality use of medicines. Medication management services such as HMRs have the potential to reduce medication related ...
    • Facilitating uptake of Aboriginal Adult Health Checks through community engagement and health promotion
      Digiacomo, Michelle; Abbott, P.; Davison, J.; Moore, L.; Davidson, Patricia (2010)
      Background: Adult Health Checks (AHCs) for Aboriginal and Torres Strait Islander people (MBS Item 710) promote comprehensive physical and psychosocial health assessments. Despite the poor uptake of health assessments in ...
    • Take-home naloxone and the politics of care
      Farrugia, A.; Fraser, S.; Dwyer, Robyn; Fomiatti, Renae; Neale, J.; Dietze, P.; Strang, J. (2019)
      'Take-home naloxone’ refers to a life-saving intervention in which a drug (naloxone) is made available to nonmedically trained people for administration to other people experiencing an opioid overdose. In Australia, it ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.